Head-to-head · membership depth vs walk-away freedom
Mochi vs Henry Meds: two opposite bets on commitment
Neither of these checkouts has been audited yet — both run on published rates, and we compare them anyway because this is the matchup for people deciding what they're actually buying: medical depth, or the freedom to leave. Mochi bets you want more medicine in your weight-loss program; Henry bets you want less friction.
Cost shapeHenry
Henry is one number — ~$149 semaglutide or ~$249 tirzepatide a month, no term. Mochi is two numbers — a $79 membership (current rate; the old $99 still circulates) plus a dose-tiered medication bill. One-part bills are easier to trust than two-part bills.
Depth of careMochi
Board-certified obesity-medicine physicians, dietitian access, unlimited visits under the membership — on published design, the deepest clinical wrap in the field. Henry's care layer is competent and thinner by intent.
LeavingHenry
Month-to-month by construction; quitting is the feature. Mochi cancels through the portal, but a membership model inherently wants you to stay subscribed.
Year-one predictabilityHenry
Multiply Henry by twelve and you're done. Mochi's year is twelve memberships plus twelve medication charges that climb with titration — unresolvable until an audit closes it.
The call: pick Mochi if the physician relationship is the product you're buying and a two-part bill doesn't spook you; pick Henry if you're testing GLP-1 therapy and want the cheapest possible goodbye. And if what you actually want is a low, fixed, single number for the whole year, that's a different model entirely — the one audited file in the field is the benchmark to price these against.